Introduction to Angelman syndrome Angelman Syndrome (AS) was originally described by Harry Angelman in 1965 and occurs in approximately one out of every 12,000 births [1, 2] . Patients with AS exhibit developmental delay, speech impairments, intellectual disability, epilepsy, abnormal EEGs (electroencephalograms), puppet-like ataxic movements, prognathism, tongue protrusion, paroxysms of laughter, abnormal sleep patterns, and hyperactivity [3] . Moreover, patients with AS often exhibit socialization and communication deficits that meet the diagnostic criteria for autism [2, 4] , but it should be noted that autism diagnosis in AS can be confounded by co-occurring developmental delay [5] .
In most cases, AS is caused by mutations or deletions of the maternally inherited UBE3A gene, which encodes a HECT (homologous to E6-associated protein C terminus) domain E3 ubiquitin ligase [6] [7] [8] . Because the paternal allele of UBE3A is epigenetically silenced (i.e., paternally imprinted) in most neurons but not other tissues (discussed below) [9] [10] [11] [12] [13] [14] , maternal inactivation of UBE3A causes a nearly complete loss of UBE3A protein selectively from the brain [14, 15] . AS typically (in $75% of cases) arises from deletions ($6 Mb in size) within chromosome 15q11-q13, a region that contains UBE3A. In $15% of cases, the maternal UBE3A allele alone is mutated [16] , indicating that selective loss of brain UBE3A function can account for most AS phenotypes. A minority of AS cases arise from microdeletions that affect imprinting at the 15q11-q13 locus ($2-4%) or from paternal uniparental disomy ($7%), where two copies of an epigenetically silenced UBE3A allele are inherited [17, 18] . Interestingly, while 15q11-q13 deletions cause AS, the most genetically identifiable form of autism results from maternal duplication of the 15q11-q13 locus encompassing UBE3A [19] [20] [21] [22] .
Although pharmacological options to control mood and sleep disorders have been partially effective [23] , in general, AS therapeutics have met with limited success. For example, frequent seizures in AS patients are especially difficult to treat. Many AS patients exhibit unique seizure types and only a fraction of these individuals respond to pharmacological intervention [24] . As another example, Levodopa (L-Dopa), which is commonly used to treat Parkinsonian symptoms, is partially effective in treating lateonset movement disorders in a subset of AS patients [25] . Moreover, efforts to unsilence the intact paternal UBE3A allele with dietary supplements that increase DNA methylation have failed [26] . The paucity of therapeutic options highlights a need to learn more about AS pathogenesis, the mechanisms of imprinting, and downstream targets of UBE3A. Answers to these questions could lead to development of novel AS therapeutics.
Review
Glossary Allele: One of two or more forms of a given DNA sequence of a gene. Genomic Imprinting: A genetic process whereby genes are differentially expressed depending on their parent-of-origin inheritance. Context-dependent fear conditioning: A behavioral paradigm where animals learn to fear a neutral stimulus when paired with a noxious or painful stimulus. Brain regions involved include the amygdala and, when cued by spatial context, the hippocampus. Epigenetic: Heritable and reversible modifications to nucleotides or chromatin that can alter gene expression without a change to DNA sequence. Ocular Dominance Plasticity: A form of experience-dependent plasticity that occurs following monocular visual deprivation whereby synaptic connections between the deprived eye and the cortex are weakened or eliminated while connections between the nondeprived eye and the cortex can be strengthened. This form of plasticity is most robust during critical periods of postnatal development. Prader-Willi syndrome: An imprinting disorder that typically results from deletions within the paternal copy of chromosome 15q11-q13. Note that deletions within the maternal copy of this chromosomal region typically result in Angelman syndrome. Prognathism: Jaw malformation due to abnormal extension or bulging of the lower jaw.
